Maybe this is what can happen or even better to Cy

Maybe this is what can happen or even better to CytoDyn / Leronlimab ... and human data is what they are apparently all asking for so let's see how it goes...

This other one which is on Nasdaq ??? went from a close of $2.41 to an open of 5.18 just before their news came out at 9:39 this morning... piqued at just after 1:00 to a high of $11.08, its 52-week high.

It's had three reverse splits since its beginnings in June 2002, most recently about a year ago.... can't find much news on it on OTC Markets for a period of time and news picked up just since March 11th of this year... not much history there. Anyone know if and when it may have uplisted to Nasdaq (think it may have been on the OTC before an uplisting: Note = Company delisted from NASDAQ on 05/12/11... and Formerly=Nile Therapeutics, Inc. until 11-2013)

https://www.otcmarkets.com/stock/CAPR/news

Wild Form 4 filings recently:

https://www.otcmarkets.com/stock/CAPR/disclosure

And strange share structure:

https://www.otcmarkets.com/stock/CAPR/security

TD Ameritrade shows:

Market Cap105.9M
Shares Outstanding12.5M